Yingtang Zhou Selected Research

Carbon Monoxide

1/2023

Gas therapy potentiates aggregation-induced emission luminogen-based photoimmunotherapy of poorly immunogenic tumors through cGAS-STING pathway activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yingtang Zhou Research Topics

Disease

2	Neoplasms (Cancer) 01/2023 - 01/2022
1	Bites and Stings (Sting) 01/2023
1	Triple Negative Breast Neoplasms 01/2023
1	Communicable Diseases (Infectious Diseases) 08/2022
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 08/2022
1	Leukemia 01/2022
1	Postmenopausal Osteoporosis 07/2013

Drug/Important Bio-Agent (IBA)

1	Carbon MonoxideIBA 01/2023
1	Mitochondrial DNA (mtDNA)IBA 01/2023
1	Glutathione (Reduced Glutathione)IBA 01/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2023
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2023
1	Interferon Type IIBA 01/2023
1	InterferonsIBA 01/2023
1	Sulfides (Thioethers)IBA 01/2023
1	CytokinesIBA 08/2022
1	Pattern Recognition ReceptorsIBA 08/2022
1	Immunologic Factors (Immunomodulators)IBA 08/2022
1	Pathogen-Associated Molecular Pattern MoleculesIBA 08/2022
1	Interleukin-6 (Interleukin 6)IBA 08/2022
1	Histones (Histone)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 07/2013

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2022
1	Immunotherapy 01/2023
1	Lasers (Laser) 01/2023
1	Photochemotherapy (Photodynamic Therapy) 01/2023
1	Phototherapy (Light Therapy) 01/2023